Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates

2 Apr 2022

Abstract excerpt

Leishmaniasis, caused by an infection of the Leishmania protozoa, is a neglected tropical disease and a major health problem in tropical and subtropical regions of the world, with approximately 350 million people worldwide at risk and 2 million new cases occurring annually. Current treatments for leishmaniasis are not highly efficacious and are associated with high costs, especially in low- and middle-income...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Research on Leishmaniasis Studies
Share to Trypanosoma species research and implications

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35456106
DOI: 10.3390/pathogens11040431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine CandidatesPMID 35456106Read ↗

Centrin-deficient <i>Leishmania mexicana</i> confers protection against Old World visceral leishmaniasisSemantic proximity Read ↗

A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editingSemantic proximity Read ↗

Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasisSemantic proximity Read ↗

<i>Leishmania</i>vaccines: progress and problemsSemantic proximity Read ↗

Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated LeishmaniaSemantic proximity Read ↗

Live attenuated Leishmania vaccines: a potential strategic alternativeSemantic proximity Read ↗

Skin resident memory cells generated by the <i>L. major</i> centrin gene deleted parasites mediate protective immune response analogous to leishmanizationSemantic proximity Read ↗

Leishmaniasis: Current Status of Vaccine DevelopmentSemantic proximity Read ↗

A Second Generation Leishmanization Vaccine with a Markerless Attenuated <i>Leishmania major</i> Strain using CRISPR gene editingSemantic proximity Read ↗

MVA-LACK as a safe and efficient vector for vaccination against leishmaniasisSemantic proximity Read ↗

Preclinical validation of a second generation leishmanization vaccine against vector transmitted fatal visceral leishmaniasisSemantic proximity Read ↗

Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.